The safety and efficacy of minimal dose of mitomycin C in trabeculectomy
Aim: To evaluate the safety and efficacy of minimal concentration and exposure time of mitomycin C (MMC) (0.1 mg/mL for 2 min) as an adjunct to trabeculectomy and to evaluate the complications of minimal dose of MMC in trabeculectomy. Background: Glaucoma ranks second as the most common cause of bli...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of the Scientific Society |
Subjects: | |
Online Access: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2016;volume=43;issue=3;spage=135;epage=139;aulast=Kotrappa |
id |
doaj-71953c822a5f4632b9b5cde87bb48937 |
---|---|
record_format |
Article |
spelling |
doaj-71953c822a5f4632b9b5cde87bb489372020-11-24T20:41:22ZengWolters Kluwer Medknow PublicationsJournal of the Scientific Society0974-50092016-01-0143313513910.4103/0974-5009.190526The safety and efficacy of minimal dose of mitomycin C in trabeculectomyRekha Bellulli KotrappaArvind Y YakkundiBhagyajyothi Balappa KhangaviAnju MeenaDhara ShahAim: To evaluate the safety and efficacy of minimal concentration and exposure time of mitomycin C (MMC) (0.1 mg/mL for 2 min) as an adjunct to trabeculectomy and to evaluate the complications of minimal dose of MMC in trabeculectomy. Background: Glaucoma ranks second as the most common cause of blindness worldwide. The introduction of MMC as an adjunct to trabeculectomy was a major advancement in the ability to improve the intraocular pressure (IOP)-lowering efficacy of the procedure. Materials and Methods: In this study, 40 patients, who had primary open-angle glaucoma, were included. Both with MMC in a dose of 0.1 mg/mL for 2 min, 20 underwent trabeculectomy alone, and 20 underwent combined surgery. Postoperative IOP at each follow-up, bleb appearance, the need for postoperative medical glaucoma treatment, and improvement of vision were recorded. We evaluated the IOP, bleb appearance, and complications on day 1, 1 week, 1 month, and 3 months postoperatively. Results: A total number of 40 patients were studied. There were 25 males and 15 females with mean age 65 ± 10 years. The IOP at 3 months follow-up was 12.0 ± 1.5 mmHg, 1 day was 17 + 1.5 mmHg, 1 week was 14.6 ± 5 mmHg, and 1 month was 12.2 ± 5 mmHg. No bleb related complications or any other complications were noted in any of the patients. In all the patients, bleb appearance was grade II-III according to Moorfields classification. Visual acuity in all the 20 patients was between 6/24 and 6/9, who underwent combined procedure. Conclusion: Trabeculectomy with intraoperative MMC in a dose of 0.1 mg/mL and exposure time of 2 min tested to be a safe and effective modality in the management of glaucoma.http://www.jscisociety.com/article.asp?issn=0974-5009;year=2016;volume=43;issue=3;spage=135;epage=139;aulast=KotrappaBlebintraocular pressure (IOP)mitomycin C (MMC)trabeculectomy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rekha Bellulli Kotrappa Arvind Y Yakkundi Bhagyajyothi Balappa Khangavi Anju Meena Dhara Shah |
spellingShingle |
Rekha Bellulli Kotrappa Arvind Y Yakkundi Bhagyajyothi Balappa Khangavi Anju Meena Dhara Shah The safety and efficacy of minimal dose of mitomycin C in trabeculectomy Journal of the Scientific Society Bleb intraocular pressure (IOP) mitomycin C (MMC) trabeculectomy |
author_facet |
Rekha Bellulli Kotrappa Arvind Y Yakkundi Bhagyajyothi Balappa Khangavi Anju Meena Dhara Shah |
author_sort |
Rekha Bellulli Kotrappa |
title |
The safety and efficacy of minimal dose of mitomycin C in trabeculectomy |
title_short |
The safety and efficacy of minimal dose of mitomycin C in trabeculectomy |
title_full |
The safety and efficacy of minimal dose of mitomycin C in trabeculectomy |
title_fullStr |
The safety and efficacy of minimal dose of mitomycin C in trabeculectomy |
title_full_unstemmed |
The safety and efficacy of minimal dose of mitomycin C in trabeculectomy |
title_sort |
safety and efficacy of minimal dose of mitomycin c in trabeculectomy |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of the Scientific Society |
issn |
0974-5009 |
publishDate |
2016-01-01 |
description |
Aim: To evaluate the safety and efficacy of minimal concentration and exposure time of mitomycin C (MMC) (0.1 mg/mL for 2 min) as an adjunct to trabeculectomy and to evaluate the complications of minimal dose of MMC in trabeculectomy. Background: Glaucoma ranks second as the most common cause of blindness worldwide. The introduction of MMC as an adjunct to trabeculectomy was a major advancement in the ability to improve the intraocular pressure (IOP)-lowering efficacy of the procedure. Materials and Methods: In this study, 40 patients, who had primary open-angle glaucoma, were included. Both with MMC in a dose of 0.1 mg/mL for 2 min, 20 underwent trabeculectomy alone, and 20 underwent combined surgery. Postoperative IOP at each follow-up, bleb appearance, the need for postoperative medical glaucoma treatment, and improvement of vision were recorded. We evaluated the IOP, bleb appearance, and complications on day 1, 1 week, 1 month, and 3 months postoperatively. Results: A total number of 40 patients were studied. There were 25 males and 15 females with mean age 65 ± 10 years. The IOP at 3 months follow-up was 12.0 ± 1.5 mmHg, 1 day was 17 + 1.5 mmHg, 1 week was 14.6 ± 5 mmHg, and 1 month was 12.2 ± 5 mmHg. No bleb related complications or any other complications were noted in any of the patients. In all the patients, bleb appearance was grade II-III according to Moorfields classification. Visual acuity in all the 20 patients was between 6/24 and 6/9, who underwent combined procedure. Conclusion: Trabeculectomy with intraoperative MMC in a dose of 0.1 mg/mL and exposure time of 2 min tested to be a safe and effective modality in the management of glaucoma. |
topic |
Bleb intraocular pressure (IOP) mitomycin C (MMC) trabeculectomy |
url |
http://www.jscisociety.com/article.asp?issn=0974-5009;year=2016;volume=43;issue=3;spage=135;epage=139;aulast=Kotrappa |
work_keys_str_mv |
AT rekhabellullikotrappa thesafetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT arvindyyakkundi thesafetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT bhagyajyothibalappakhangavi thesafetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT anjumeena thesafetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT dharashah thesafetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT rekhabellullikotrappa safetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT arvindyyakkundi safetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT bhagyajyothibalappakhangavi safetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT anjumeena safetyandefficacyofminimaldoseofmitomycincintrabeculectomy AT dharashah safetyandefficacyofminimaldoseofmitomycincintrabeculectomy |
_version_ |
1716825430415114240 |